Sort
39,280 grants matching “leukemia”
Ehrlichia T1S Effector Regulation of Host Gene Transcription
$383,651Jere W McBride · University Of Texas Med Br Galveston · R01 · FY2016 · AI
New methods for structural variation analysis of rearranged cancer genomes using
$383,639Mikhail Kolmogorov · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Imaging the stem cell niche in regeneration and cancer
$383,625Tannishtha Reya · University Of California, San Diego · R01 · FY2012 · HL
Pro-apoptotic BID in DNA Damage and Leukemogenesis
$383,609Sandra S Zinkel · Vanderbilt University · R01 · FY2010 · HL
Pro-apoptotic BID in DNA Damage and Leukemogenesis
$383,609Sandra S Zinkel · Vanderbilt University · R01 · FY2007 · HL
Pro-apoptotic BID in DNA Damage and Leukemogenesis
$383,609Sandra S Zinkel · Vanderbilt University · R01 · FY2009 · HL
Pro-apoptotic BID in DNA Damage and Leukemogenesis
$383,609Sandra S Zinkel · Vanderbilt University · R01 · FY2008 · HL
Pro-apoptotic BID in DNA Damage and Leukemogenesis
$383,609Sandra S Zinkel · Vanderbilt University · R01 · FY2011 · HL
Project 1: Targeting the MYC Pathway in Prostate Cancer
$383,608Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2025 · CA
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
$383,606Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2023 · CA
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
$383,606Gregory Joseph Riggins · Johns Hopkins University · R01 · FY2022 · CA
Arginine deiminase as an Anti-Cancer Therapy
$383,600Phoenix Pharmacologics, Inc. · R44 · FY2001 · CA
Ehrlichia T1S Effector Regulation of Host Gene Transcription
$383,574Jere W McBride · University Of Texas Med Br Galveston · R01 · FY2017 · AI
Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation
$383,572Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
$383,563Jeroen Roose · University Of California, San Francisco · R01 · FY2022 · CA
Molecular understanding of leukemic bone marrow cytokine-Ras signals and metabolic dependence
$383,563Jeroen Roose · University Of California, San Francisco · R01 · FY2025 · CA
SYNTHESIS OF BIOACTIVE COMPLEX ALKALOIDS
$383,555Derek S Tan · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia
$383,548Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2021 · CA
Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis
$383,525John L. Cleveland · Scripps Florida · R01 · FY2014 · CA
Innate Immune Therapy for B-Cell Malignancies
$383,456John C Byrd · Ohio State University · P01 · FY2012 · CA
Function of MTG16/ETO2 in acute leukemia
$383,450Scott Hiebert · Vanderbilt University · R01 · FY2007 · HL
Modulating signaling pathways in endothelial cells to abate leukemic progression.
$383,445Jason Mathew Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Modulating signaling pathways in endothelial cells to abate leukemic progression.
$383,445Jason Mathew Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Identification and Significance of Biologic Mediators in Red Cell Concentrates
$383,438Neil Blumberg · University Of Rochester · R01 · FY2010 · HL
Targeting vulnerabilities of PPM1D-mutant gliomas
$383,426Pratiti Bandopadhayay · Dana-Farber Cancer Inst · R37 · FY2024 · CA